기본 정보
- CAS
10030-90-7- 표준 SMILES
O=C([O-])CCC(=O)[O-].[Fe+2]- InChIKey
MDXRFOWKIZPNTA-UHFFFAOYSA-L- 분자식
- C4H4FeO4
- 평균 분자량
- 171.92 g/mol
- 단동위원소 질량
- 171.94589611
개요
RN given refers to Fe(+2)(1:1) salt; important as iron supplement
이름 및 식별자
- 우선 이름
- Ferrous succinate
- IUPAC
- butanedioate;iron(2+)
- 현지명
- 숙신산철
- 영어명
- iron succinate
- 분자식
- C4H4FeO4
- 분자량
- 171.91716
이름 및 동의어
Ferrous succinate10030-90-7Butanedioic acid, iron(2+) salt (1:1)Ferrlecit 2FERROMYNIron succinate (fe(o4c4h4))818ZYK7N91butanedioic acid, iron (+2) saltferrosuccinateRefChem:921575233-082-3Iron succinate
이름 더 보기
숙신산철EisensuccinatEisensuccinat CASIron(II)-succinateEisen(II)-succinatferrous succinic acidbutanedioate,iron(2+)iron succinate USP/EP/BPSuccinic acid iron(II) saltFERROUSSUCCINATE,18.5%,POWDER
iron(II) succinatebutanedioate;iron(2+)Succinic acid iron(II) salt;Succinic acid iron(II) saltUNII-818ZYK7N91EINECS 233-082-3Ferplex (TN)SCHEMBL275423FERROUS SUCCINATE [MI]
데이터베이스 식별자
- CAS
10030-90-7- PubChem CID
- 10464762
- DTXSID
DTXSID101373453- ChEMBL
CHEMBL3707232- UNII
- 818ZYK7N91
물성
구조 계산 물성
- 극성 표면적
- 80.3 Ų
- 수소 결합 공여자 수
- 0
- 수소 결합 수용자 수
- 4
- 회전 가능 결합 수
- 1
- 무거운 원자 수
- 9
- 형식 전하
- 0
- 복잡도
- 81.6
물리화학적 성질
- InChI
- InChI=1S/C4H6O4.Fe/c5-3(6)1-2-4(7)8;/h1-2H2,(H,5,6)(H,7,8);/q;+2/p-2
- InChIKey
- MDXRFOWKIZPNTA-UHFFFAOYSA-L
- SMILES
- C1(=O)O[Fe]OC(=O)CC1
안전 및 규제
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
GHS 분류
GHS ClassificationNot Classified
유해성 정보
Regulatory InformationChemical: Butanedioic acid, iron(2+) salt (1:1)
Hazard Classes and CategoriesNot Classified
안전 데이터
- 기존화학 물질
- KE-16969
화학 및 산업
약리 정보
ATC Code
B - Blood and blood forming organs
QB - Blood and blood forming organs
PharmacodynamicsThe major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Mechanism of ActionIron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
MeSH Pharmacological ClassificationAgents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.
Absorption, Distribution and Excretion
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
응용 분야
용도Iron succinate is an oral iron supplement for the treatment of iron deficiency (ID). Iron succinate increases ferritin and transferrin saturation in non-anaemic heart failure and iron deficient patients and can significantly increase iron uptake in patients with heart failure (HF), nearly doubling ferritin levels and increasing TSAT. Patients with HFrEF or HFpEF appear to have a similar response[1].
공급사76 곳
Shandong chuangyingchemical Co., Ltd.18853181302 · [email protected]
湖南韵邦生物科技股份有限公司
관련 반응
0건
현재 필터 조건에 해당하는 반응 기록이 없습니다.
화합물 노트
불러오는 중…